Promoter Hypermethylation of Multiple Genes in Sputum Precedes Lung Cancer Incidence in a High-Risk Cohort
Open Access
- 15 March 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (6) , 3338-3344
Abstract
A sensitive screening approach for lung cancer could markedly reduce the high mortality rate for this disease. Previous studies have shown that methylation of gene promoters is present in exfoliated cells within sputum prior to lung cancer diagnosis. The purpose of the current study is to conduct a nested case-control study of incident lung cancer cases from an extremely high-risk cohort for evaluating promoter methylation of 14 genes in sputum. Controls (n = 92) were cohort members matched to cases (n = 98) by gender, age, and month of enrollment. The comparison of proximal sputum collected within 18 months to >18 months prior to diagnosis showed that the prevalence for methylation of gene promoters increased as the time to lung cancer diagnosis decreased. Six of 14 genes were associated with a >50% increased lung cancer risk. The concomitant methylation of three or more of these six genes was associated with a 6.5-fold increased risk and a sensitivity and specificity of 64%. This is the first study to prospectively examine a large panel of genes for their ability to predict lung cancer and shows the promise of gene promoter hypermethylation in sputum as a molecular marker for identifying people at high risk for cancer incidence. (Cancer Res 2006; 66(6): 3338-44)Keywords
This publication has 36 references indexed in Scilit:
- Gene Promoter Methylation in Plasma and Sputum Increases with Lung Cancer RiskClinical Cancer Research, 2005
- Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokersInternational Journal of Cancer, 2004
- RASSF4/AD037 Is a Potential Ras Effector/Tumor Suppressor of the RASSF FamilyCancer Research, 2004
- Hypermethylation of the GATA Genes in Lung CancerClinical Cancer Research, 2004
- Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancersInternational Journal of Cancer, 2004
- K-ras and p16INK4Aalterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokersLung Cancer, 2004
- Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokersInternational Journal of Cancer, 2003
- Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patientsOncogene, 2003
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Early Lung Cancer Action ProjectAnnals of the New York Academy of Sciences, 2001